Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Peter Safir has been practicing in the food and drug field for over 25 years and is widely recognized in the pharmaceutical industry as one of the leading food and drug regulatory lawyers in the country.  In recent years, Mr. Safir has worked primarily with the research-based pharmaceutical industry concentrating on marketing practices, life cycle management, and issues involving drug quality and manufacturing.

  • Represented PhRMA in the drafting of the PhRMA Code on the relationship between PhRMA members and healthcare professionals.
  • Represented Johnson & Johnson in obtaining pediatric exclusivity for Duragesic and successfully defended FDA grant in the District Court and Court of Appeals.
  • Represented Pfizer in obtaining pediatric exclusivity for Diflucan and successfully defended the grant in District Court.
  • Counsel to the Independent Panel of Guidant Corporation investigating implantable defibrillators.
  • Counsel to numerous research based companies on FDA regulatory strategies.

Memberships and Affiliations

  • Princeton University Class of 1967, Class Secretary (1992-2002)
  • Princeton University Class of 1967, Vice President
  • Corcoran Gallery of Art, Trustee (1992-1994)
  • Corcoran College of Art and Design, Board of Overseers (1996-2002)
  • The Food and Drug Law Institute, Distinguished Service and Leadership Award (2014)
  • Chosen by Chambers & Partners to appear in their Chambers USA Guide as a leading Washington, DC attorney in the field of Healthcare: Pharmaceutical/Medical Products Regulatory (2006-2020) and Life Sciences: Regulatory/Compliance (2014-2020).
  • Chambers Global, Life Sciences: Regulatory/Compliance (2020-2021)
  • The International Who's Who of Life Sciences Lawyers (2012)
  • PLC Life Sciences, Which Lawyer? for Regulatory (2005-2012)
  • Recognized in the Legal Times "Leading Lawyers" series as being a top food & drug attorney in Washington DC (2005-2006).
  • Named in Best Lawyers In America for his work in FDA law (2007-2020).
  • The Best Lawyers in America, Washington FDA Lawyer of the Year (2012)  
  • Legal 500 US, "Leading Lawyer" - Healthcare: Life Sciences (2014, 2019)
  • Legal 500 US, Healthcare: Life Sciences (2013-2017)
  • Washington DC Super Lawyers, FDA (2012-2020) 
  • LMG Life Sciences, "Life Science Star" (2013)
  • Washingtonian, Best Lawyers (2011, 2013)
  • Named in Euromoney's Expert Guides to the World's Leading Lawyers as being a leading attorney in the healthcare field (2006).